# § 522.2065   Rabacfosadine.

(a) *Specifications.* Each vial of powder contains 16.4 milligrams (mg) rabacfosadine. Each milliliter of constituted solution contains 8.2 mg rabacfosadine.


(b) *Sponsor.* See No. 058198 in § 510.600(c) of this chapter.


(c) *Conditions of use in dogs*—(1) *Amount.* Administer rabacfosadine at 1 mg/kilogram body weight as a 30-minute intravenous infusion, once every 3 weeks, for up to 5 doses.


(2) *Indications for use.* For the treatment of lymphoma in dogs.


(3) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.



---

[N] [87 FR 10969, Feb. 28, 2022]




